GMCSF Side Effects

6399571-8 | Arrhythmia, Loss Of Consciousness, Pleural Effusion, Supraventricular Tachycardia, Syncope
on Oct 13, 2009 Male patient from UNITED STATES , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Gmcsf (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), loss of consciousness, pleural effusion, supraventricular tachycardia, syncope. Gmcsf dosage: 250ug/m2 Qd X 14 Days Sq Followed By 7 Days Off. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FLOMAX (View Flomax Review and Flomax Label ). Patient was hospitalized.

6268168-2 | Syncope
Patient was taking Gmcsf (View Usage). Patient had the following side effects: syncope on Jul 13, 2009 from UNITED STATES Additional patient health information: Male patient , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Gmcsf dosage: 250 Mg/m2 Qd X 14 Days And Off 14 Days Sq. During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ), NEXIUM (View Nexium Review and Nexium Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ). Patient was hospitalized.

6244287-1 | Activities Of Daily Living Impaired, Anaemia, Asthenia, Dizziness, Fatigue, Gait Disturbance
Adverse event was reported on Jun 23, 2009 by a Male patient taking Gmcsf (View Usage) (Dosage: 500 Mcg Qd X 14 Days Followed By 14 Days Off Sq) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 83 years of age, After Gmcsf was administered, patient had the following side effects: activities of daily living impaired, anaemia, asthenia, dizziness (What is dizziness?), fatigue, gait disturbance. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ZOMETA (View Zometa Review and Zometa Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LUPRON (View Lupron Review and Lupron Label ). Patient was hospitalized.

6237989-4 | Escherichia Urinary Tract Infection
on Jun 17, 2009 Male patient from UNITED STATES , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Gmcsf (View Usage). Patient experienced the following unwanted or unexpected effects: escherichia urinary tract infection. Gmcsf dosage: 250 Mg/m2 Qd X 14 Days And Off For 14 Days Sq. During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ), NEXIUM (View Nexium Review and Nexium Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ). Patient was hospitalized.


6139575-3 | Dizziness, Fatigue
on Mar 30, 2009 Male patient from UNITED STATES , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Gmcsf (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fatigue. Gmcsf dosage: 500 Mcg Qd X 14 Days Sq. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LUPRON (View Lupron Review and Lupron Label ), ZOMETA (View Zometa Review and Zometa Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), SENNEKOT (View Sennekot Review and Sennekot Label ). Patient was hospitalized.

6110981-6 | Aspiration, Dyspnoea, Oral Candidiasis, Pneumonia
Patient was taking Gmcsf (View Usage). After Gmcsf was administered, patient had the following side effects: aspiration, dyspnoea, oral candidiasis, pneumonia (What is pneumonia?) on Mar 10, 2009 from UNITED STATES Additional patient health information: Male patient , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Gmcsf dosage: 250 Mg/m2 Qd X 14 Days And Off For 14 Days Sq. During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ), NEXIUM (View Nexium Review and Nexium Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ), FLOWMAX (View Flowmax Review and Flowmax Label ). Patient was hospitalized.

6100133-8 | Urinary Tract Infection
Adverse event was reported on Feb 27, 2009 by a Male patient taking Gmcsf (View Usage) (Dosage: 250 Mg/m2 Qd X 14 Days And Off For 14 Days Sq) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 97 years of age, Patient experienced the following unwanted or unexpected effects: urinary tract infection (What is urinary tract infection?). During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ), NEXIUM (View Nexium Review and Nexium Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ), FLOWMAX (View Flowmax Review and Flowmax Label ). Patient was hospitalized.

6064319-3 | Candidiasis, Dyspnoea
on Feb 03, 2009 Male patient from UNITED STATES , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Gmcsf (View Usage). Patient had the following side effects: candidiasis, dyspnoea. Gmcsf dosage: 250mg/m2 Qd X 14 Days And Off For 14 Days Sq. During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ), NEXIUM (View Nexium Review and Nexium Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ), FLOWMAX (View Flowmax Review and Flowmax Label ). Patient was hospitalized.

6056589-2 | Pneumonia, Urinary Tract Infection, White Blood Cell Count Increased
on Jan 26, 2009 Male patient from UNITED STATES , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Gmcsf (View Usage). After Gmcsf was administered, patient had the following side effects: pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?), white blood cell count increased. Gmcsf dosage: 250mg/m2 Qd X 14days And Off For 14 Days Sq. During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ), NEXIUM (View Nexium Review and Nexium Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ), FLOWMAX (View Flowmax Review and Flowmax Label ). Patient was hospitalized.

5498497-1 | Adrenal Insufficiency
Patient was taking Gmcsf (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency on Oct 25, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 175.5 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Gmcsf dosage: 500mg Days 1-14 Sc. Patient was hospitalized.

5385048-5 | Fall, Limb Injury, Thrombosis
Adverse event was reported on Jul 10, 2007 by a Male patient taking Gmcsf (View Usage) (Dosage: 250mg/m2 Days 1-14 Injection) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , weighting 192.9 lb, Patient had the following side effects: fall (What is fall?), limb injury, thrombosis. Patient was hospitalized.